Diagonal Bio Feed

	Est. tid*
2025-10-31	08:00	Kvartalsrapport 2025-Q3
2025-08-22	08:00	Kvartalsrapport 2025-Q2
2025-05-21	N/A	X-dag ordinarie utdelning DIABIO 0.00 SEK
2025-05-20	N/A	Årsstämma
2025-05-14	-	Kvartalsrapport 2025-Q1
2025-03-28	-	Bokslutskommuniké 2024
2025-01-17	-	Extra Bolagsstämma 2024
2024-10-31	-	Kvartalsrapport 2024-Q3
2024-08-22	-	Kvartalsrapport 2024-Q2
2024-06-12	-	X-dag ordinarie utdelning DIABIO 0.00 SEK
2024-06-11	-	Årsstämma
2024-05-31	-	Kvartalsrapport 2024-Q1
2024-02-28	-	Bokslutskommuniké 2023
2023-10-31	-	Kvartalsrapport 2023-Q3
2023-09-22	-	Extra Bolagsstämma 2023
2023-08-22	-	Kvartalsrapport 2023-Q2
2023-05-12	-	X-dag ordinarie utdelning DIABIO 0.00 SEK
2023-05-11	-	Årsstämma
2023-05-11	-	Kvartalsrapport 2023-Q1
2023-02-23	-	Bokslutskommuniké 2022
2022-11-23	-	Extra Bolagsstämma 2022
2022-11-16	-	Kvartalsrapport 2022-Q3
2022-08-23	-	Kvartalsrapport 2022-Q2
2022-05-12	-	X-dag ordinarie utdelning DIABIO 0.00 SEK
2022-05-11	-	Årsstämma
2022-05-11	-	Kvartalsrapport 2022-Q1
2022-02-23	-	Bokslutskommuniké 2021
2021-10-29	-	Kvartalsrapport 2021-Q3
2021-08-27	-	Kvartalsrapport 2021-Q2

Land	Sverige
Lista	Nordic SME Sweden
Sektor	Hälsovård
Industri	Medicinteknik

2025-05-16 12:45:00 Diagonal Bio secures 100 percent of forthcoming warrant exercise through pre-subscription and underwriting commitments 0,01 SEK | 0,00%

2025-05-14 08:00:00 Diagonal Bio publishes interim report for the first quarter of 2025 0,01 SEK | 0,00%

2025-05-05 14:50:00 Diagonal Bio accelerates its commercialisation efforts with the appointment of Anders Wallseth as Senior Commercial Advisor 0,01 SEK | -7,14%

2025-04-29 08:00:00 Diagonal Bio publishes the Annual Report for 2024 0,01 SEK | 0,00%

2025-04-25 08:00:00 Diagonal Bio announces change of news plattform 0,01 SEK | 0,00%

2025-04-14 11:05:15 Kallelse till årsstämma i Diagonal Bio AB 0,01 SEK | 0,00%

2025-03-28 08:45:00 Diagonal Bio announces additional pilot tests of LAMPlify® 0,01 SEK | +7,14%

2025-03-28 08:00:00 Diagonal Bio publishes Year-End Report for 2024 0,01 SEK | +7,14%

2025-03-21 14:00:00 Diagonal Bio granted patent in Japan 0,01 SEK | -6,25%

2025-03-19 14:00:00 Nomination Committee change in Diagonal Bio AB (publ.) 0,01 SEK | +3,45%

2025-03-19 08:30:00 Trading in Diagonal Bio’s shares and warrants of series TO 2 on NGM Nordic SME begins today 0,01 SEK | +3,45%

2025-03-13 09:45:00 Stall Courant and Diagonal Bio agree to a pilot test of LAMPlify® 0,01 SEK | +5,88%

2025-03-04 16:44:41 Diagonal Bio has been approved for delisting from Nasdaq First North Growth Market 0,01 SEK | -3,47%

2025-03-04 15:42:40 Diagonal Bio has received conditional approval for listing on NGM Nordic SME 0,01 SEK | -3,47%

2025-03-03 09:54:46 Diagonal Bio applies for change of marketplace to NGM Nordic SME 0,01 SEK | -3,36%

2025-02-19 14:45:00 Diagonal Bio AB’s announces last day of trading in BTU and first day of trading in warrants of series TO 2 0,02 SEK | -4,76%

2025-02-18 14:30:00 Diagonal Bio AB resolves on a directed issue of units to all external underwriters 0,02 SEK | +8,00%

2025-02-12 15:45:00 Diagonal Bio’s CEO Karin Wehlin increases ownership 0,03 SEK | +35,87%

2025-02-07 16:15:00 Diagonal Bio AB’s rights issue of units oversubscribed 0,02 SEK | -5,39%

2025-02-05 19:45:00 Stall Goop conducts pilot test of LAMPlify® 0,02 SEK | -6,47%

2025-01-29 09:40:00 Diagonal Bio announces positive pilot test results and secures order from StallZet 0,02 SEK | +2,92%

2025-01-23 08:30:00 The subscription period of Diagonal Bio AB’s rights issue of units commences today 0,02 SEK | -10,82%

2025-01-22 08:30:00 Diagonal Bio AB publishes investment memorandum prior to upcoming rights issue of units 0,02 SEK | -15,65%

2025-01-17 15:30:00 Nomination Committee change in Diagonal Bio (publ.) 0,02 SEK | -2,44%

2025-01-17 13:45:00 Bulletin from the Extraordinary General Meeting of Diagonal Bio AB on 17 January 2025 0,02 SEK | -2,44%

2025-01-14 22:00:00 Diagonal Bio expands its testing panel for horses with EHV-5 detection 0,01 SEK | -2,21%

2024-12-23 23:02:13 Kallelse till extra bolagsstämma i Diagonal Bio AB 0,02 SEK | -6,98%

2024-12-23 22:54:25 The Board of Directors of Diagonal Bio AB resolves on a directed issue of units and a rights issue of units to focus on validation of LAMPlify®’s commercial interest 0,02 SEK | -6,98%

2024-12-23 21:46:53 Diagonal Bio enters into a strategic partnership with Daniel Redén at StallZet to enhance commercialisation plans 0,02 SEK | -6,98%

2024-11-22 12:30:00 Renowned horse race jockey and trainer conducts pilot test of LAMPlify® 0,02 SEK | +3,05%

2024-11-18 16:00:00 Valberedning utsedd i Diagonal Bio AB (publ) inför årsstämman 2025 0,02 SEK | +9,09%

2024-11-18 16:00:00 Nomination Committee appointed for Diagonal Bio 0,02 SEK | +9,09%

2024-11-13 15:00:00 Diagonal Bio announces pilot test with LAMPlify® at Kolgjini Stables 0,02 SEK | +8,57%

2024-11-11 08:00:00 Diagonal Bio announces that it is exploring financing options 0,02 SEK | -4,18%

2024-10-31 15:00:00 Diagonal announces first pilot test at a stud with LAMPlify® 0,03 SEK | +10,47%

2024-10-31 08:00:00 Diagonal Bio AB Third Quarter Report (Q3 2024) 0,03 SEK | +10,47%

2024-10-25 14:15:00 Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences 0,03 SEK | +8,75%

2024-10-22 14:31:28 Diagonal Bio will present LAMPlify® at a partnered event for trainers at Jägersro 0,03 SEK | +13,11%

2024-10-11 14:30:00 Diagonal Bio announces successful external validation of LAMPlify® for viruses in pigs 0,03 SEK | +41,42%

2024-10-08 19:00:00 Hunneberga Horse Stable to conduct pilot test of LAMPlify® 0,02 SEK | -6,25%

2024-10-03 12:15:00 Horse trainer Daniel Redén at StallZet will conduct a pilot with LAMPlify® 0,01 SEK | +3,53%

2024-10-02 17:34:18 Diagonal Bio AB’s warrant exercise registered at the Swedish Companies Registration Office 0,01 SEK | 0,00%

2024-09-27 12:38:00 Diagonal Bio AB announces the outcome of the exercise of warrants of series TO 1 0,01 SEK | +4,44%

2024-09-19 08:30:00 The last day of trading in warrants of series TO 1 is on the 24th of September 2024 0,01 SEK | -6,94%

2024-09-12 08:30:00 The exercise period for warrants of series TO 1 commences today 0,01 SEK | -4,12%

2024-09-11 09:00:00 The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share 0,01 SEK | -15,00%

2024-09-06 11:30:00 Diagonal Bio announces successful external validation of LAMPlify® for respiratory viruses in horses 0,01 SEK | +1,40%

2024-08-22 08:00:00 Diagonal Bio AB Second Quarter Report (Q2 2024) 0,02 SEK | -7,06%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Diagonal Bio

Prenumeration

Kalender

Beskrivning

Diagonal Bio

Prenumeration

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden